Semiglutide is an injection that is FDA approved for weight management.

For your first appointment, you’ll need to book a consultation with our healthcare team. Before coming in, you’ll need to complete some blood tests and confirm that you are under the supervision of a PCP, or Primary Care Physician. During your consultation, our medical professionals will assess whether semaglutide is an appropriate and safe choice for you, based on FDA guidelines for obesity treatment. This appointment involves a thorough review of your medical history, current medications, vital statistics, and BMI.

You are NOT a suitable candidate for semaglutide if you have any of the following conditions: diabetic eye disease, hypoglycemia, impaired kidney function, pancreatitis, gastrointestinal issues, gallbladder disease, medullary thyroid carcinoma (or a family history of it), or multiple endocrine neoplasia type 2. This also applies if you are pregnant, planning to become pregnant, or breastfeeding.

Semiglutide Results:

Semaglutide is among the most effective weight management medications available. However, don’t expect rapid weight loss. Typically, individuals lose around 1-3 pounds per week, although this can vary. Combining semaglutide with a calorie-restricted diet and regular physical activity will enhance your results.

If you have health issues related to excess weight, you should notice improvements with treatment. Many report reductions in cholesterol, blood pressure, and blood sugar levels. Most patients reach their weight and health objectives within six months to a year and generally have more long-term success compared to those who haven’t used semaglutide.

During your personal consultation, we will discuss the advantages of semaglutide for weight management and set realistic expectations for your treatment journey.

The starting dose for semaglutide is usually 0.25 mg per week, increasing by 0.25 mg every four weeks until the desired dose is achieved, as tolerated. Side effects like nausea and digestive discomfort are common, especially during dose adjustments. Consistency in weekly subcutaneous injections is crucial.

Semiglutide is an FDA-approved injectable medication for long-term weight management. On average, users lose about 15% of their initial body weight.

• Enhances satiety, curtails hunger and cravings

• Reduces body weight, waist circumference, and inflammation

• Administered weekly via subcutaneous injections

• Average weight loss is around 15% of initial body weigh.

Semiglutide weight loss benefits

• FDA-approved, long-term weight loss when combined with diet and exercise

• Average weight loss is about 15% of starting body weight

• Helps stabilize blood sugar levels

• Promotes digestive efficiency, leading to prolonged feelings of fullness

• Targets brain centers to reduce appetite, thereby helping to counteract leptin resistance (a hormone affecting metabolism and weight)

• Enhances metabolic rate and fat-burning capabilities, reducing insulin resistance and glycogen levels

• Helps curb the desire for quick sugar fixes by maintaining stable glucose levels.

Semiglutide works by simulating a hormone known as glucagon-like-peptide-1 (GLP-1), which influences brain regions that control hunger and food consumption. It serves as a potent appetite suppressant and also aids in stabilizing blood sugar levels.